PMID: 25760072Mar 12, 2015Paper

Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR

Oncotarget
Sang Yun HaJhingook Kim

Abstract

The aim of this study was to determine the distribution of known oncogenic driver mutations in female never-smoker Asian patients with lung adenocarcinoma. We analyzed 214 mutations across 26 lung cancer-associated genes and three fusion genes using the MassARRAY LungCarta Panel and the ALK, ROS1, and RET fusion assays in 198 consecutively resected lung adenocarcinomas from never-smoker females at a single institution. EGFR mutation, which was the most frequent driver gene mutation, was detected in 124 (63%) cases. Mutation of ALK, KRAS, PIK3CA, ERBB2, BRAF, ROS1, and RET genesoccurred in 7%, 4%, 2.5%, 1.5%, 1%, 1%, and 1% of cases, respectively. Thus, 79% of lung adenocarcinomas from never-smoker females harbored well-known oncogenic mutations. Mucinous adenocarcinomas tended to have a lower frequency of known driver gene mutations than other histologic subtypes. EGFR mutation was associated with older age and a predominantly acinar pattern, while ALK rearrangement was associated with younger age and a predominantly solid pattern. Lung cancer in never-smoker Asian females is a distinct entity, with the majority of these cancers developing from oncogenic mutations.

References

May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincent A MillerRobert T Heelan
Sep 21, 2007·Nature Reviews. Cancer·Sophie SunAdi F Gazdar
Apr 21, 2009·Expert Review of Anticancer Therapy·Lynn T Tanoue, Frank C Detterbeck
Jun 18, 2009·Current Opinion in Oncology·Giorgio V ScagliottiSilvia Novello
Aug 5, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuJason A Zell
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alice T ShawA John Iafrate
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott J RodigLucian R Chirieac
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Dec 17, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Benjamin SolomonD Ross Camidge
Feb 26, 2010·Annals of Surgical Oncology·Tsuyoshi TakahashiHiroshi Date
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Jul 2, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Myung-Ju AhnSai-Hong Ignatius Ou
Sep 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yihua SunHongbin Ji
Dec 16, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yoon Hee ChoiIm Il Na
Jan 22, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisDavid Yankelewitz
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Nov 11, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L V SequistD Dias-Santagata
Jan 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristin BergethonA John Iafrate
Feb 10, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yang ZhangHaiquan Chen
Feb 14, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J De GrèveD Schallier
Feb 14, 2012·Nature Medicine·Takashi KohnoTatsuhiro Shibata
Dec 25, 2012·Genes & Cancer·Ahmed El-Telbany, Patrick C Ma
Apr 27, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Natasha RekhtmanAndre L Moreira
Jun 1, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DeardenD Blowers
Jan 28, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Min Hwan KimByoung Chul Cho
May 23, 2014·JAMA : the Journal of the American Medical Association·Mark G KrisPaul A Bunn

❮ Previous
Next ❯

Citations

Oct 7, 2017·BMC Bioinformatics·Santosh PhilipsLang Li
Nov 20, 2016·Oncotarget·Yadong WangHaiyan Yang
Jul 15, 2017·British Journal of Biomedical Science·N MohamadP Rajadurai
Apr 12, 2016·Tuberculosis and Respiratory Diseases·Ji Young Park, Seung Hun Jang
Mar 31, 2016·Cancer Science·Motonobu SaitoTakashi Kohno
Aug 14, 2019·Expert Review of Proteomics·Toshihide NishimuraHisashi Saji
Nov 6, 2018·The Journal of Nursing Research : JNR·Chia-Chen YangMei-Ling Chen
Nov 9, 2018·Journal of Clinical Medicine·Sophia SubatYuichi Ishikawa
Jul 21, 2016·Applied Immunohistochemistry & Molecular Morphology : AIMM·Xiaoli JiaChunyan Wu
Jan 8, 2021·Respiratory Research·Ya-Sian ChangJan-Gowth Chang
Mar 9, 2021·The Oncologist·Richard J LeeEvan Y Yu
Jul 9, 2021·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Edward Christopher DeeScarlett Lin Gomez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.